CVS Health Corporation (NYSE:CVS) Quarterly growth Review


Quarterly Sales and EPS Roundup:

CVS Health Corporation (NYSE:CVS) reported sales (ttm) of 172.7 Billion, whereas, 19 number of analysts estimated the mean sale of 46492.4 million. The analysts estimated sales for the higher end at 47613 million and lower end at 45826.8 million while the year ago reported sale was 44800 million.

13 number of analysts have estimated the sales of the company for the quarter ending Feb 7, 2017- Feb 13, 2017, analysts estimated mean sale target of 45573.6 million while high and low sale targets are estimated at 47513 million and 43804 million respectively.

CVS Health Corporation (NYSE:CVS) reported earning per shares for the quarter ending Nov 08 BMO at 1.64, whereas, 21 number of analysts estimated the mean EPS at 1.68. The analysts estimated EPS for the higher end at 1.8 and lower end at 1.64 while the year ago reported earnings per share was 1.69.

The company has mean EPS estimate of 1.23 reported by 15 number of analyst for the quarter ending Feb 7, 2017- Feb 13, 2017. The analysts estimated mean EPS at 1.23 while the high and low EPS estimate stand at 1.37 and 1.16 respectively. In contrast to the year ago quarter EPS was at 1.44. EPS long term mean growth rate estimated by 5 analysts is at 12.05%, whereas, the high and low Long term growth rate estimated at 20.4 and 6.95.

Valuation Ratios of CVS Health Corporation (NYSE:CVS) versus the Industry and Sector:

Let’s have a look at some of the important valuation ratios of the CVS Health Corporation (NYSE:CVS). These ratios are important while doing valuation of the company or the shares of the company.

CVS Health Corporation (NYSE:CVS) currently has P/E (Price to Earnings) ratio of 15.83 while the company’s industry has 19.45 P/E and the sector P/E is 39. Similarly, the company’s last 5 years high P/E ratio is 24.24 and low P/E is 15.73, whereas, the industry’s and sector’s  high P/E for the past year is 24.54 and 41.84 respectively and low P/E ratio for the last 5 years is 11.83 for the industry and 24.27 for the Sector.

Beta is also an important valuation ratio for analyzing the stock of the company, 14 has Beta of 0.83 while its industry and Sector’s beta remains at 0.6 and 0.65 respectively.

Price to Sale ratio of 14 stands at 0.46 while Price to Book Ratio stands at 2.2. Its Price to Cash Flow ratio shows the value of 10.52, whereas, the industry and sector ratio of Price to Cash Flow ticked at 13.33 and 34.08 respectively.

5 Year Growth Rate Analysis:

Growth rates are very important while analyzing the long term growth and valuation of a certain company.

5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of CVS Health Corporation (NYSE:CVS) stands at 9.86 while the industry’s and the sector’s growth for next 5 years ticked at 8.63 and 12.88 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 13.3 and 3.38.

CVS Health Corporation (NYSE:CVS) Trading Statistics:

The company surged 1.33% and closed its last trading session at $75.88. The market capitalization of the company is at $82 Billion. The stock touched 52-week High of $106.67 on May 9, 2016 and 52-week Low of $69.3 on Nov 8, 2016. The stock currently has Weekly Volatility of 1.55% and Monthly Volatility of 2.24%. The Beta for the company stands at 0.81 and its Average True Range (ATR) shows a value of 1.77.